期刊文献+

冠状动脉药物洗脱支架置入术后支架内再狭窄的临床研究进展 被引量:3

Advances in restenosis after drug-eluting stent implantation in coronary artery
下载PDF
导出
摘要 药物洗脱支架虽然很大程度上降低了再狭窄的发生率,但仍有部分患者在随访期间发生再狭窄,甚至需要再次干预病变血管。目前关于药物洗脱支架置入术后再狭窄的临床研究主要集中在预测因素、治疗上,本文就相关临床研究的最新进展作一综述。 Drug-eluting stent (DES) can greatly decrease the incidence of restenosis, but restenosis still occurs in some patients after DES implantation, thus needing target lesion revascularization (TLR). Clinical studies at present are focused on the prediction and treatment of restenosis after DES implantation. Following is a review of its update advances.
出处 《解放军医学院学报》 CAS 2014年第3期292-295,共4页 Academic Journal of Chinese PLA Medical School
基金 国家科技支撑计划(2009BAI86B04) 总后勤部保健专项课题(13BJZ49) 解放军总医院博士研究生创新基金(12BCZ07)~~
关键词 药物洗脱支架 支架内再狭窄 临床研究 进展 drug-eluting stent in-stent restenosis clinical study progress
  • 相关文献

参考文献6

  • 1Harald Rittger,Johannes Brachmann,Anil-M. Sinha,Matthias Waliszewski,Marc Ohlow,Andreas Brugger,Holger Thiele,Ralf Birkemeyer,Volkhard Kurowski,Ole-A. Breithardt,Martin Schmidt,Stefan Zimmermann,Sandra Lonke,Moritz von Cranach,The-Vinh Nguyen,Werner G. Daniel,Jochen W?hrle.A Randomized, Multicenter, Single-Blinded Trial Comparing Paclitaxel-Coated Balloon Angioplasty With Plain Balloon Angioplasty in Drug-Eluting Stent Restenosis[J].Journal of the American College of Cardiology.2012(15)
  • 2Vasim Farooq,David van Klaveren,Ewout W Steyerberg,Emanuele Meliga,Yvonne Vergouwe,Alaide Chieffo,Arie Pieter Kappetein,Antonio Colombo,David R Holmes,Michael Mack,Ted Feldman,Marie-Claude Morice,Elisabeth St?hle,Yoshinobu Onuma,Marie-angèle Morel,Hector M Garcia-Garcia,Gerrit Anne van Es,Keith D Dawkins,Friedrich W Mohr,Patrick W Serruys.Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II[J].The Lancet.2013(9867)
  • 3Robert A Byrne,Franz-Josef Neumann,Julinda Mehilli,Susanne Pinieck,Britta Wolff,Klaus Tiroch,Stefanie Schulz,Massimiliano Fusaro,Ilka Ott,Tareq Ibrahim,J?rg Hausleiter,Christian Valina,Jürgen Pache,Karl-Ludwig Laugwitz,Steffen Massberg,Adnan Kastrati.Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial[J].The Lancet.2012
  • 4Seung-Whan Lee,Jung-Min Ahn,Seungbong Han,Gyung-Min Park,Young-Rak Cho,Woo-Seok Lee,Jeong-Yoon Jang,Chang-Hee Kwon,Jong-Young Lee,Won-Jang Kim,Soo-Jin Kang,Young-Hak Kim,Cheol-Whan Lee,Jae-Joong Kim,Seong-Wook Park,Seung-Jung Park.Differential Impact of Cilostazol on Restenosis According to Implanted Stent Type (from a Pooled Analysis of Three DECLARE Randomized Trials)[J].The American Journal of Cardiology.2013
  • 5Xavier Freixa,Ali S. Almasood,Sohail Q. Khan,Karen Mackie,Mark Osten,Douglas Ing,Christopher B. Overgaard,Eric M. Horlick,Peter H. Seidelin,Vladimír D?avík.Choice of stent and outcomes after treatment of drug‐eluting stent restenosis in highly complex lesions[J].Cathet Cardiovasc Intervent.2012(1)
  • 6Kiyotake Ishikawa,Yutaka Aoyama,Katsuhiro Kato,Akihito Tanaka,Mizuho Hiramatsu,Masayoshi Ajioka,Haruo Kamiya,Toshikazu Tanaka,Haruo Hirayama.Treatment of Sirolimus‐Eluting Stent Restenosis: Additional Stent, Balloon Angioplasty, and Coronary Artery Bypass Graft[J].J Card Surg.2013(2)

同被引文献46

  • 1田美蓉,李莉,赵碧琼,耿学斌,刘小坤,闫华.切割球囊在小血管病变介入治疗中的应用[J].山东医药,2007,47(4):32-32. 被引量:2
  • 2王秀兰,崔红,侯安存,等.临床药物治疗学[M].8版.北京:人民卫生出版社,2007:93-95.
  • 3侯青,乔树宾,高润霖,等.冠状动脉支架术后再狭窄的预测因素[J].中华心血管病杂志,2005,33(增刊):61-64.
  • 4胡健,沈卫峰,张建盛,等.冠状动脉内支架置入术后再狭窄与尿酸的关系[J].中华心血管病杂志,2002,30(增刊):270.
  • 5Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary: systematic review and recommendations: a scientific statement from the American Heart Association[J]. Circulation, 2014, 129(12): 1350-1369.
  • 6Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction[J]. J Gen Intern Med, 2006, 21(1): 30-38.
  • 7Kuijpers PM, Hamulyak K, Strik JJ, et al. Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patents with maior del3ression[J]. Psychiatry Res. 2002. 109(2~: 207-210.
  • 8Suh JW, Lee SP, Park KW, et al. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol- based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial[J]. J Am Coil Cardiol, 2011, 57(3): 280-289.
  • 9国家药典委员.临床用药须知·化学药和生物制品卷[M].2010年版.北京:中国医药科技出版社,2011:4.
  • 10Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction[J]. Circulation, 2001, 104(16): 1894-1898.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部